Assembly Biosciences, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2020 | $-63.0M | $-63.4M | $470.0K | $21.9M |
| FY2021 | $-93.4M | $-96.5M | $3.1M | $5.2M |
| FY2022 | $-84.5M | $-84.6M | $102.0K | $6.6M |
| FY2023 | $22.7M | $22.5M | $255.0K | $5.1M |
| FY2024 | $-51.1M | $-51.1M | $28.0K | $3.1M |